GL1X · GenesisL1 explorer

Research workbench

A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits nipah virus and hendra virus infection

Analyse A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6TYS
Type
protein
Length
2,022 residues
Chains
9
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fusion glycoprotein F0; 5B3 antibody heavy chain; 5B3 antibody light chain
UniProt
Q9IH63
Ligands
NAG, MAN, BMA
Pockets
20 · best druggability 0.78

Structure

electron microscopy · 3 distinct chains · 25% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, EFusion glycoprotein F0protein44736% helix, 28% strandQ9IH63
H, C, F5B3 antibody heavy chainprotein1205% helix, 48% strand—
L, D, G5B3 antibody light chainprotein1073% helix, 50% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 24 copies · chains A, B, E
  • MAN · alpha-D-mannopyranose · sugar · 12 copies
  • BMA · beta-D-mannopyranose · sugar · 3 copies

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 11 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110830.780.8062empty
29500.770.80105empty
310430.770.79113empty
410880.740.77105empty
510740.730.77105empty

Interfaces

15 interfaces between chains.

  • A–B · 2696 Ų buried · 26 hydrogen bonds · protein-protein
  • B–E · 2688 Ų buried · 26 hydrogen bonds · protein-protein
  • A–E · 2683 Ų buried · 26 hydrogen bonds · protein-protein
  • C–D · 863 Ų buried · 8 hydrogen bonds · protein-protein
  • F–G · 863 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 24 disulfide, 12 glycan (disulfide, N-glycosylation).

Compared structures

  • 6TYS · A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah… · the same entry in another collection · chain G against G, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.